Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Nasal Irrigation vs Fluticasone Nasal Spray in Allergic Rhinitis
NCT06858423Phase 4Completed
- Sponsor
- Benha University
- Start
- Aug 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of EPI-EE in allergic rhinitis (AR) (3 arms), sponsored by Benha University. Primary endpoint: Clinical improvement at 1 month. Started Aug 2023; status: completed.
02
Drugs
EPI-EE
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT06858423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06858423.